Glioma risk associated with extent of estimated European genetic ancestry in African Americans and Hispanics.

Saved in:
Bibliographic Details
Title: Glioma risk associated with extent of estimated European genetic ancestry in African Americans and Hispanics.
Authors: Ostrom QT; Department of Medicine, Section of Epidemiology and Population Sciences, Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX., Egan KM; Division of Population Sciences, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL., Nabors LB; Neuro-Oncology Program, University of Alabama at Birmingham, Birmingham, AL., Gerke T; Division of Population Sciences, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL., Thompson RC; Department of Neurological Surgery, Vanderbilt University Medical Center, Nashville, TN., Olson JJ; Department of Neurosurgery, Emory University School of Medicine, Atlanta, GA., LaRocca R; Department of Hematology-Oncology, Norton Cancer Institute, Louisville, KY., Chowdhary S; Neuro-Oncology Program, Lynn Cancer Institute, Boca Raton, FL., Eckel-Passow JE; Division of Biomedical Statistics and Informatics, Mayo Clinic College of Medicine, Rochester, MN., Armstrong G; Department of Medicine, Section of Epidemiology and Population Sciences, Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX., Wiencke JK; Department of Neurological Surgery, School of Medicine, University of California, San Francisco, San Francisco, CA., Bernstein JL; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, NY, New York., Claus EB; School of Public Health, Yale University, New Haven, CT.; Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA., Il'yasova D; Department of Epidemiology and Biostatistics, School of Public Health, Georgia State University, Atlanta, GA.; Cancer Control and Prevention Program, Department of Community and Family Medicine, Duke University Medical Center, Durham, NC.; Duke Cancer Institute, Duke University Medical Center, Durham, NC., Johansen C; Oncology Clinic, Finsen Center, Rigshospitalet and Survivorship Research Unit, The Danish Cancer Society Research Center, Copenhagen, Denmark., Lachance DH; Department of Neurology, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, MN., Lai RK; Department of Neurology and Preventive Medicine, Keck School of Medicine, University of Southern California, CA, Los Angeles., Merrell RT; Department of Neurology, NorthShore University HealthSystem, Evanston, IL., Olson SH; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, NY, New York., Sadetzki S; Cancer and Radiation Epidemiology Unit, Gertner Institute, Chaim Sheba Medical Center, Tel Hashomer, Israel.; Department of Epidemiology and Preventive Medicine, School of Public Health, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel., Schildkraut JM; Department of Public Health Sciences, University of Virginia School of Medicine, Charlottesville, VA., Shete S; Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX., Houlston RS; Division of Genetics and Epidemiology, The Institute of Cancer Research in Sutton, Surrey, United Kingdom., Jenkins RB; Department of Laboratory Medicine and Pathology, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, MN., Wrensch MR; Department of Neurological Surgery, School of Medicine, University of California, San Francisco, San Francisco, CA., Melin B; Department of Radiation Sciences, Umeå University, Umeå, Sweden., Amos CI; Institute for Clinical and Translational Research, Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX., Huse JT; Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, TX., Barnholtz-Sloan JS; Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, OH., Bondy ML; Department of Medicine, Section of Epidemiology and Population Sciences, Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX.
Source: International journal of cancer [Int J Cancer] 2020 Feb 01; Vol. 146 (3), pp. 739-748. Date of Electronic Publication: 2019 Apr 22.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1097-0215
DOI:10.1002/ijc.32318